Kanoria Chemicals swings to ₹26.4 Cr consolidated profit in Q1 FY27 from year-ago loss
revenue +128.62% · margins expanding
₹460.37 Cr
+128.62% YoY
₹26.36 Cr
5.64%
+8.7pp YoY
₹6.03
Kanoria Chemicals & Industries reported consolidated Q1 FY27 (quarter ended 30 June 2026) revenue from operations of ₹460.37 Cr and net profit of ₹26.36 Cr (EPS ₹6.03), against a loss of ₹13.78 Cr (EPS -₹1.79) in the year-ago quarter — a clean YoY turnaround; standalone PAT was near-identical at ₹26.37 Cr (EPS ₹6.03), so basis divergence is negligible here. No street consensus or brokerage preview specific to this quarter could be located, and the company has no formal prior guidance on record, so vs-street and vs-guidance both read unknown rather than assumed.
Q1 FY-2027 vs prior quarters
Two base effects sit under the headline and need adjusting for. First, the year-ago comparatives on our records (revenue ₹453.78 Cr, loss ₹13.78 Cr) still carried APAG Holding AG, the Swiss subsidiary the company lost control of on 31 July 2025, which this filing now retrospectively shows as discontinued operations for that quarter (₹253.18 Cr of income, a ₹13.23 Cr post-tax loss). Stripping that out, the comparable continuing-operations base was ₹201.38 Cr revenue and a ₹0.55 Cr loss — so this quarter's ₹460.37 Cr and ₹26.36 Cr represent roughly 129% like-for-like revenue growth and a genuine swing to profit on the retained Chemicals-plus-Textile business, not the ~1% the raw headline-to-headline comparison would imply. Second, sequentially, PBT more than doubled to ₹35.24 Cr from ₹17.00 Cr in Q4 FY26, yet reported PAT fell 16.6% QoQ (₹26.36 Cr vs ₹31.62 Cr) purely because Q4 FY26 carried a one-off ~₹18.44 Cr deferred-tax credit; this quarter's ₹8.88 Cr tax charge is a normal ~25% effective rate on PBT.
For context: revenue is at a 6-quarter high.
Operating margin (revenue less operating opex, excluding finance costs/depreciation/other income) was 9.78% this quarter versus 8.90% in Q4 FY26 and 3.61% a year ago — the YoY jump is mostly the APAG exit (a low-margin, loss-making business) rather than a genuine step-up: on a like-for-like continuing-ops basis, year-ago OPM was already close to 9.0%, so underlying margin is roughly flat to mildly better. Net margin's apparent QoQ dip to 5.65% of total income from 10.15% is the tax base-effect above, not operating deterioration. By segment, Chemicals (the standalone business) contributed ₹429.99 Cr revenue and ₹35.25 Cr PBT; Textile — the Ethiopia-based Kanoria Africa Textiles subsidiary — added ₹30.38 Cr revenue and swung to a ₹2.59 Cr segment profit from a ₹3.49 Cr loss a year ago. A sharp rise in Purchase of Stock-in-Trade (₹141.53 Cr this quarter vs ₹6.05 Cr a year ago, alongside Cost of Materials Consumed up to ₹234.54 Cr from ₹136.10 Cr) is the visible driver of the topline jump, pointing to expanded trading/distribution volumes; the filing carries no management commentary or press release explaining this shift, so the driver is inferred from the expense lines, not stated by the company.
W1
Whether the elevated Purchase of Stock-in-Trade (₹141.53 Cr this quarter vs ₹6.05 Cr YoY) is a sustainable new trading/distribution line or a one-off bulk purchase — watch next quarter's stock-in-trade volume and gross margin.
W2
Tax normalization: this quarter's ~25% effective rate (₹8.88 Cr tax on ₹35.24 Cr PBT) should be the new run-rate now that Q4 FY26's ~₹18.44 Cr one-off deferred-tax credit has rolled off — confirm in Q2 FY27.
W3
Textile segment (Kanoria Africa Textiles, Ethiopia) profitability — swung from a ₹3.49 Cr segment loss a year ago to a ₹2.59 Cr profit this quarter; confirm this holds rather than reverting.